Children Severe Traumatic Skin Lesions and Functional Outcome

Burns Clinical Trial

Official title:

Children Severe Traumatic Skin Lesions and Functional Outcome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02804607
• Other study ID #: PI2016_843_0019
• Status: Completed
• Start date: January 18, 2016
• Est. completion date: February 8, 2016

Study information

• Verified date: August 2018
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Traumatic skin lesions require an adapted and early patient care management

Description:

Traumatic skin lesions and in particular the burns which happen to growing children are complex and require an adapted and early patient care management. A child presents physical, psychological, and physiological characteristics which involve a specific functional prognosis. The aim of the study was to evaluate the functional outcome after a mid-term period from a severe skin traumatism occurring during childhood and which had required an initial graft.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 51
• Est. completion date: February 8, 2016
• Est. primary completion date: February 8, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• children who were hospitalized for an extensive and deep skin lesion on at least one joint, at CHU Amiens, from April 1999 to December 2014, in the Physical and Rehabilitation Pediatric activity center.

• And with a serious skin lesion:

• What the total dermal area is estimated to be less than 25%

• Taking at least one articulation

• Dont a part is at least 2nd degree deep or third degree

Exclusion Criteria:

• First degree burns or superficial second degree Burns resulting in death in the acute phase

• A history of pre-burn disorders affecting growth

• Escarres

Related Conditions & MeSH terms

• Burns

Intervention

Other:
• questionnaire

Locations

Country	Name	City	State
France	CHU Amiens	Amiens

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	autonomy	for daily life activities (questionnaire)	5 years
Secondary	appearance of contractures	consultation follow-up	5 years
Secondary	limited joint mobility	consultation follow-up	5 years